Advanced Wound Care: A Future Built On Innovation

The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.

Global aging demographics along with increases in diabetes and obesity are providing a solid foundation for growth of the advanced wound care market. Hard-to-heal wounds, which encompass not only diabetic, venous, pressure, and arterial ulcers, but also burns, trauma, and challenging surgical wounds, are difficult to treat since many do not heal for weeks, months, or even years. The prevalence of patients with hard-to-heal wounds is staggering, totaling roughly 50 million in the key countries across the world. A typical patient seen at a hospital-based outpatient wound clinic has at least 12 comorbidities and averages two wounds or ulcers, according to Ostomy Wound Management, and 60% of patients with diabetic foot ulcers and 50% of those with venous ulcers do not heal.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

South Korea Adds Digital Health Rules To Already Complicated Regulatory Landscape

 
• By 

A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.

Switzerland Investigates Private Sector Assessment of FDA-Approved Medical Devices

 

Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.

Abbott Embeds Libre Glucose Data In Epic EHR, Expanding Digital Health Footprint

 
• By 

Through this partnership, data stored in LibreView – Abbott’s cloud-based diabetes data management system – can automatically flow into Epic, allowing clinicians using Epic to view a patient’s CGM data before, during and after visits without toggling between systems or requesting manual uploads.